1995
DOI: 10.1055/s-0038-1649870
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of Hemophilia B Carriers Using Two Novel Dinucleotide Polymorphisms and Hha I RFLP of the Factor IX Gene in Japanese Subjects

Abstract: SummaryWe identified two novel dinucleotide polymorphisms in intron A at nucleotide 192 (FIX 192) and in the 5’ flanking region at nucleotide -793 (FIX-793) of the factor IX gene, which are present in normal Japanese. The Hha I restriction fragment length polymorphism (FIX-Hhal) located 8 kb 3’ to the factor IX gene was also found to be an efficient marker for detecting carriers in a Japanese family with hemophilia B. Each of these polymorphisms was able to be rapidly ascertained by the polymerase chain reacti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

1996
1996
2008
2008

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 4 publications
1
14
0
Order By: Relevance
“…After obtaining informed consent from all patients, blood samples from the patients, family members, and healthy volunteers were collected in a 1/ 10 volume of 3.13% sodium citrate. Plasma was separated by centrifugation at  2000g for 20 min, and genomic DNA was isolated from peripheral blood leukocytes as previously described [7].…”
Section: Patients and Sample Preparationsmentioning
confidence: 99%
“…After obtaining informed consent from all patients, blood samples from the patients, family members, and healthy volunteers were collected in a 1/ 10 volume of 3.13% sodium citrate. Plasma was separated by centrifugation at  2000g for 20 min, and genomic DNA was isolated from peripheral blood leukocytes as previously described [7].…”
Section: Patients and Sample Preparationsmentioning
confidence: 99%
“…It was also mentioned that although the study of restriction fragment length polymorphisms is the preferred method in familial haemophilia, it is less useful in isolated cases [14]. DNA polymorphism studies also revealed that some single polymorphic sites can assess the carrier status up to approximately 30% whereas three or more probes can give the results up to 90% [15][16][17][18][19]. In another study, racial variations were also seen, i.e.…”
Section: Resultsmentioning
confidence: 99%
“…To analyse the X chromosome haplotype of the family members, we used polymorphic markers, such as monoamine oxidase A gene ( MAOA , Xp11.23) promoter [18], androgen receptor gene ( AR , Xq11–12) [19], phosphoglycerate kinase 1 gene ( PGK1 , Xq13.3) [16], glutamate receptor ionotropic AMPA 3 gene ( GRIA3 , Xq25–26) [17], FIX gene ( F9 ‐ 793, Xq27.1–2) [20] and Fragile X mental retardation gene 1 ( FMR1 , Xq27.3) [16]. We also analysed short tandem repeat [13] polymorphisms, such as reference SNP IDs: rs3223331 (Xq22), rs3220745 (Xq24) and rs3220178 (Xq26).…”
Section: Patients Materials and Methodsmentioning
confidence: 99%